Compare ARK Genomic Revolution ETF (ARKG) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs State Street Technology Select Sector SPDR ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while State Street Technology Select Sector SPDR ETF trades at $183.25. Which is the better fit depends on your goals.
| ARKG | XLK | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $198.21 |
52-Week Low | $23.09 | $127.49 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XLK, the Technology Select Sector SPDR ETF, trades at $185.79, up 0.24% today, with a bullish technical signal driven by moving averages. It has gained 33% year-to-date as of July 2026, outperforming the Nasdaq-100, supported by strong tech earnings and sector inflows. A dividend of $0.23 is scheduled for June 2026.
The outlook remains positive given robust tech fundamentals and institutional optimism, but risks include market concentration, Fed policy shifts, and potential valuation pressures. Wall Street sentiment is bullish, though some investors are reducing mega-cap tech exposure ahead of key guidance updates.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About State Street Technology Select Sector SPDR ETF
XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →
